MRNA icon

Moderna
MRNA

Upgrade to unlock
Buy
Hold
Sell

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$38
29% downside
High target

7 analyst ratings

positive
6  neutral
86%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Piper Sandler
Piper Sandler
Edward Tenthoff
100% 1-yr MRNA win rate
23 Feb ‘26 5 days ago
Goldman Sachs
Goldman Sachs
Salveen Richter
17 Feb ‘26 11 days ago
RBC Capital
RBC Capital
Luca Issi
17 Feb ‘26 11 days ago
Evercore ISI Group
Evercore ISI Group
Cory Kasimov
17 Feb ‘26 11 days ago
UBS
UBS
Eliana Merle
50% 1-yr MRNA win rate
7 Jan ‘26 1 month ago
Morgan Stanley
Morgan Stanley
Matthew Harrison
12 Dec ‘25 2 months ago
Jefferies
Jefferies
Andrew Tsai
12 Dec ‘25 2 months ago